Butterfly Network (BFLY) Cash from Financing Activities (2020 - 2026)
Butterfly Network (BFLY) reported Cash from Financing Activities of $2.3 million for Q1 2026, down 97.06% on a YoY basis from $78.5 million in Q1 2025, and up 236.47% sequentially from -$1.7 million in Q4 2025.
Butterfly Network (BFLY) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Butterfly Network (BFLY) has 7 years of Cash from Financing Activities data on file, last reported at $2.3 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 97.06% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (down 97.92% YoY), and the FY2025 full-year result was $77.8 million, up 5301.47% from the prior year.
- Cash from Financing Activities improved to $2.3 million in Q1 2026, from -$1.7 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $78.5 million in Q1 2025 to a low of -$1.7 million in Q4 2025.
- A 5-year average of $7.4 million and a median of $159000.0 in 2022 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities slumped 99.9% in 2022 and fell 13.18% in 2025, its largest moves.
- Tracing BFLY's Cash from Financing Activities over 5 years: stood at $137000.0 in 2022, then tumbled by 32.85% to $92000.0 in 2023, then tumbled by 1725.0% to -$1.5 million in 2024, then dropped by 13.18% to -$1.7 million in 2025, then surged by 236.47% to $2.3 million in 2026.
- Business Quant data shows BFLY's Cash from Financing Activities at $2.3 million in Q1 2026, -$1.7 million in Q4 2025, and $987000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -25.00 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 21.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -26.93 Mn |
| 10 | Butterfly Network | 1.79 Bn | 1.65 Bn | 18.29 Mn | 2.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.31 Mn |
| Mar 31, 2026 | 2.31 Mn |
| Dec 31, 2025 | -1.69 Mn |
| Dec 31, 2025 | -1.69 Mn |
| Jun 30, 2025 | 987,000.00 |
| Jun 30, 2025 | 987,000.00 |
| Mar 31, 2025 | 78.47 Mn |
| Mar 31, 2025 | 78.47 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Sep 30, 2023 | 92,000.00 |
| Sep 30, 2023 | 92,000.00 |
| Jun 30, 2023 | 136,000.00 |
| Jun 30, 2023 | 136,000.00 |
| Dec 31, 2022 | 137,000.00 |
| Dec 31, 2022 | 137,000.00 |
| Sep 30, 2022 | 2.04 Mn |
| Sep 30, 2022 | 2.04 Mn |
| Jun 30, 2022 | 159,000.00 |
| Jun 30, 2022 | 159,000.00 |